Pre-Clinical Studies Archives | Page 34 of 40 | Novotec Medical & Stratec Medizintechnik

t2023est22nut0ss5zer

20 Jan 2025

20. January 2025

Skeletal effects of estrogen deficiency as induced by an aromatase inhibitor in an aged male rat model

Aromatization of androgens into estrogens may be important for maintenance of the male skeleton. To address this hypothesis, we evaluat...

t2023est22nut0ss5zer

20 Jan 2025

20. January 2025

Spontaneous fracture (sfx): a mouse genetic model of defective peripubertal bone formation

A new mouse model of stage-specific bone growth failure and fracture has been recovered as an autosomal recessive mutation, designated ...

t2023est22nut0ss5zer

20 Jan 2025

20. January 2025

How cancellous and cortical bones adapt to loading and growth hormone

There is great interest in the relationships between growth hormone (GH), muscle loading and bone, in part, because GH increases muscle...

t2023est22nut0ss5zer

20 Jan 2025

20. January 2025

PTH and interactions with bisphosphonates

We report that a therapeutic dose of the antiresorptive bisphosphonate alendronate administered to skeletally mature rats for the durat...

t2023est22nut0ss5zer

20 Jan 2025

20. January 2025

Modulation of Strain Sensing: A New Approach for the Treatment of Osteoporosis

t2023est22nut0ss5zer

20 Jan 2025

20. January 2025

Mineral density and bone strength are dissociated in long bones of rat osteopetrotic mutations

Bone mineral density (BMD) and mechanical strength generally show strong positive correlations. However, osteopetrosis is a metabolic b...

t2023est22nut0ss5zer

20 Jan 2025

20. January 2025

Effects of dietary calcium depletion and repletion on dynamic determinants of tibial bone volume in two inbred strains of mice

As an adjunct to our efforts to identify the genes that determine peak bone density, we examined phenotypic differences between two inb...

t2023est22nut0ss5zer

20 Jan 2025

20. January 2025

Bone resorption induced by 1 alpha,25 dihydroxyvitamin D(3) in vivo is not altered by inactivation of the plasminogen activator inhibitor 1

One of the proteolytic systems produced by bone cells is the plasminogen activator/plasmin pathway, which involves the two plasminogen ...

t2023est22nut0ss5zer

20 Jan 2025

20. January 2025

Anabolic effect of aminoterminally truncated fibroblast growth factor 4 (FGF4) on bone

Fibroblast growth factor 4 (FGF4), a member of the FGF family, plays several important roles in bone development during embryogenesis. ...

t2023est22nut0ss5zer

20 Jan 2025

20. January 2025

Parathyroid hormone and growth hormone have additive or synergetic effect when used as intervention treatment in ovariectomized rats with established osteopenia

The severely osteoporotic human skeleton is characterized by thin cortices and a very fragile cancellous framework. To increase the bio...

Skeletal effects of estrogen deficiency as induced by an aromatase inhibitor in an aged male rat model

Spontaneous fracture (sfx): a mouse genetic model of defective peripubertal bone formation

How cancellous and cortical bones adapt to loading and growth hormone

PTH and interactions with bisphosphonates

Modulation of Strain Sensing: A New Approach for the Treatment of Osteoporosis

Mineral density and bone strength are dissociated in long bones of rat osteopetrotic mutations

Effects of dietary calcium depletion and repletion on dynamic determinants of tibial bone volume in two inbred strains of mice

Bone resorption induced by 1 alpha,25 dihydroxyvitamin D(3) in vivo is not altered by inactivation of the plasminogen activator inhibitor 1

Anabolic effect of aminoterminally truncated fibroblast growth factor 4 (FGF4) on bone

Parathyroid hormone and growth hormone have additive or synergetic effect when used as intervention treatment in ovariectomized rats with established osteopenia

TÜV certified

Made in Germany

Proven quality

Research studies

Active worldwide

Product groups

Service

About us